EYPT

EyePoint Pharmaceuticals, Inc. - Common Stock (EYPT)

About EyePoint Pharmaceuticals, Inc. - Common Stock (EYPT)

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Details

Daily high

$5.70

Daily low

$5.46

Price at open

$5.51

52 Week High

$13.98

52 Week Low

$3.91

Market cap

385.3M

Dividend yield

0.00%

Volume

364,897

Avg. volume

664,422

P/E ratio

-2.33

EyePoint Pharmaceuticals, Inc. - Common Stock News